Search research articles
Contact Us
Filters
Showing results (151-160 of 177) with videos related to
Page
of 18
Sort By:
Respiratory Medicine
|
November 20, 2025
Impact of telemedicine in long-term CPAP therapy: A twelve-month follow-up study in Japan utilizing propensity score matching
Daisuke Endo, Toshiki Akahoshi, Kenichi Nagaoka, et al.
Thoracic Cancer
|
December 14, 2023
Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants
Yuta Ohishi, Yoko Nakanishi, Yukari Hirotani, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 28, 2020
Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression
Kazushige Wakuda, Michitoshi Yabe, Hiroaki Kodama, et al.
JCI Insight
|
November 3, 2018
A humanized mouse model to study asthmatic airway inflammation via the human IL-33/IL-13 axis
Ryoji Ito, Shuichiro Maruoka, Kaori Soda, et al.
BMC Pulmonary Medicine
|
July 1, 2026
3D CT-Based quantification of airway structural changes during asthma exacerbations: a retrospective observational study
Ryosuke Ozoe, Kenji Mizumura, Yosuke Nemoto, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 10, 2019
Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases
Eriko Miyawaki, Hirotsugu Kenmotsu, Keita Mori, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
May 8, 2020
High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study
Chie Morimoto, Hisako Matsumoto, Tomoko Tajiri, et al.
Scientific Reports
|
April 1, 2024
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma
Yuko Iida, Kazushige Wakuda, Hirotsugu Kenmotsu, et al.
International Journal of Clinical Oncology
|
January 8, 2021
Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy
Nobuaki Mamesaya, Koji Muramatsu, Michitoshi Yabe, et al.
Respiratory Investigation
|
July 1, 2025
Clinical outcomes, safety, and potential prognostic factors of noninvasive respiratory support in patients with COVID-19: A Japanese multicenter observational study
Jiro Ito, Toshiki Yokoyama, Aiko Tanaka, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 177) with videos related to
Sort By:
Page
of 18
Respiratory Medicine
|
November 20, 2025
Impact of telemedicine in long-term CPAP therapy: A twelve-month follow-up study in Japan utilizing propensity score matching
Daisuke Endo, Toshiki Akahoshi, Kenichi Nagaoka, et al.
Thoracic Cancer
|
December 14, 2023
Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants
Yuta Ohishi, Yoko Nakanishi, Yukari Hirotani, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 28, 2020
Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression
Kazushige Wakuda, Michitoshi Yabe, Hiroaki Kodama, et al.
JCI Insight
|
November 3, 2018
A humanized mouse model to study asthmatic airway inflammation via the human IL-33/IL-13 axis
Ryoji Ito, Shuichiro Maruoka, Kaori Soda, et al.
BMC Pulmonary Medicine
|
July 1, 2026
3D CT-Based quantification of airway structural changes during asthma exacerbations: a retrospective observational study
Ryosuke Ozoe, Kenji Mizumura, Yosuke Nemoto, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 10, 2019
Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases
Eriko Miyawaki, Hirotsugu Kenmotsu, Keita Mori, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
May 8, 2020
High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study
Chie Morimoto, Hisako Matsumoto, Tomoko Tajiri, et al.
Scientific Reports
|
April 1, 2024
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma
Yuko Iida, Kazushige Wakuda, Hirotsugu Kenmotsu, et al.
International Journal of Clinical Oncology
|
January 8, 2021
Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy
Nobuaki Mamesaya, Koji Muramatsu, Michitoshi Yabe, et al.
Respiratory Investigation
|
July 1, 2025
Clinical outcomes, safety, and potential prognostic factors of noninvasive respiratory support in patients with COVID-19: A Japanese multicenter observational study
Jiro Ito, Toshiki Yokoyama, Aiko Tanaka, et al.
Page
of 18